Litcius/Paper detail

BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy

Barry Paul, Cesar Rodriguez, Saad Z. Usmani

2022Drugs28 citationsDOIOpen Access PDF

Topics & Concepts

MedicineChimeric antigen receptorMultiple myelomaBortezomibImmunologyTargeted therapyMonoclonal antibodyProteasome inhibitorAntibodyOncologyCancer researchImmunotherapyInternal medicineImmune systemCancerCAR-T cell therapy researchMultiple Myeloma Research and TreatmentsMonoclonal and Polyclonal Antibodies Research
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma Therapy | Litcius